Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             35 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A phase II study of tivozanib in patients with metastatic and nonresectable soft-tissue sarcomas Agulnik, M.

28 1 p. 121-127
artikel
2 Circulating tumour cells and pathological complete response: independent prognostic factors in inflammatory breast cancer in a pooled analysis of two multicentre phase II trials (BEVERLY-1 and -2) of neoadjuvant chemotherapy combined with bevacizumab Pierga, J.-Y.

28 1 p. 103-109
artikel
3 Coincidence of immunotherapy-associated hemophagocytic syndrome and rapid tumor regression Takeshita, M.

28 1 p. 186-189
artikel
4 Common breast cancer risk alleles and risk assessment: a study on 35 441 individuals from the Danish general population Näslund-Koch, C.

28 1 p. 175-181
artikel
5 Cyclin D mediates tolerance of genome-doubling in cancers with functional p53 Crockford, A.

28 1 p. 149-156
artikel
6 Developmental therapeutics for patients with breast cancer and central nervous system metastasis: current landscape and future perspectives Costa, R.

28 1 p. 44-56
artikel
7 Do Contemporary Randomized Controlled Trials Meet ESMO Thresholds for Meaningful Clinical Benefit? Del Paggio, J.C.

28 1 p. 157-162
artikel
8 Editorial board
28 1 p. ii-iii
artikel
9 Erlotinib and acid suppressive agents: is it worth to take a coke? Retamero, A.

28 1 p. 192-193
artikel
10 Fulminant type 1 diabetes caused by dual immune checkpoint blockade in metastatic renal cell carcinoma Teló, G.H.

28 1 p. 191-192
artikel
11 ‘Genotype/immunotype’ correlations in resected NSCLC Paik, P.K.

28 1 p. 7-8
artikel
12 Immunohistochemistry to determine mismatch repair-deficiency in endometrial cancer: the appropriate standard Powell, M.A.

28 1 p. 9-10
artikel
13 Impact of early palliative care on caregivers of patients with advanced cancer: cluster randomised trial McDonald, J.

28 1 p. 163-168
artikel
14 Is the routine use of trimodality therapy for selected patients with non-small cell lung cancer supported by long-term clinical outcomes? Dickhoff, C.

28 1 p. 185
artikel
15 Monitoring of somatic mutations in circulating cell-free DNA by digital PCR and next-generation sequencing during afatinib treatment in patients with lung adenocarcinoma positive for EGFR activating mutations Iwama, E.

28 1 p. 136-141
artikel
16 Multicenter randomized phase II study of cisplatin and fluorouracil plus docetaxel (DCF) compared with cisplatin and fluorouracil plus Adriamycin (ACF) as preoperative chemotherapy for resectable esophageal squamous cell carcinoma (OGSG1003) Yamasaki, M.

28 1 p. 116-120
artikel
17 Mutant KIT as imatinib-sensitive target in metastatic sinonasal carcinoma Dieter, S.M.

28 1 p. 142-148
artikel
18 Mutation profiles in early-stage lung squamous cell carcinoma with clinical follow-up and correlation with markers of immune function Choi, M.

28 1 p. 83-89
artikel
19 Next steps in immuno-oncology: enhancing antitumor effects through appropriate patient selection and rationally designed combination strategies Salama, A.K.S.

28 1 p. 57-74
artikel
20 PARP inhibition in BRCA2-mutated prostate cancer Nientiedt, C.

28 1 p. 189-191
artikel
21 Pathway level alterations rather than mutations in single genes predict response to HER2-targeted therapies in the neo-ALTTO trial Shi, W.

28 1 p. 128-135
artikel
22 Phase I/II trial of cabazitaxel plus abiraterone in patients with metastatic castration-resistant prostate cancer (mCRPC) progressing after docetaxel and abiraterone Massard, C.

28 1 p. 90-95
artikel
23 Practical guidance for mismatch repair-deficiency testing in endometrial cancer Stelloo, E.

28 1 p. 96-102
artikel
24 Prevention of fluoropyrimidine toxicity: do we still have to try our patient's luck? Danesi, R.

28 1 p. 183
artikel
25 Quantitative proteomic analysis of HER2 expression in the selection of gastric cancer patients for trastuzumab treatment An, E.

28 1 p. 110-115
artikel
26 3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3) Cardoso, F.

28 1 p. 16-33
artikel
27 Recommendation on testing for dihydropyrimidine dehydrogenase deficiency in the ESMO consensus guidelines for the management of patients with metastatic colorectal cancer Deenen, M.J.

28 1 p. 184
artikel
28 Statistical controversies in clinical research: basket trials, umbrella trials, and other master protocols: a review and examples Renfro, L.A.

28 1 p. 34-43
artikel
29 Table of Contents
28 1 p. iv-vi
artikel
30 Targeting angiogenesis in advanced soft tissue sarcoma: tivozanib—hype or me-too? Mir, O.

28 1 p. 13-15
artikel
31 Thanks to referees 2016
28 1 p. 1-6
artikel
32 The potential and perils of observational studies Buyse, M.

28 1 p. 182
artikel
33 The search for simplicity: is this compatible with precision medicine? Nuciforo, P.G.

28 1 p. 10-12
artikel
34 Vectorized gene therapy of liver tumors: proof-of-concept of TG4023 (MVA-FCU1) in combination with flucytosine Husseini, F.

28 1 p. 169-174
artikel
35 Whole-exome sequencing and immune profiling of early-stage lung adenocarcinoma with fully annotated clinical follow-up Kadara, H

28 1 p. 75-82
artikel
                             35 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland